Introduction
"activation" loop (e.g., p70␣1Thr252 [12] ), and the other (e.g. p70␣1Thr412) is located in the conserved segment The p70 S6 kinase (p70S6K) is activated downstream of insulin and growth factor receptors through a complex carboxyterminal to the catalytic domain, in the sequence FXXFTY [13, 14] . Modification at either site alone gives sequence of multiple phosphorylations. Most steps in this activation mechanism have been elucidated in consisignificant activation; however, physiologic activation requires the simultaneous phosphorylation at both sites, derable, if not quite complete, detail, primarily through studies on the p70␣ isoform [1, 2] . The more recently which creates a strong, positively cooperative site-site inidentified p70␤ isoform shares with p70␣ all of the phosteraction [15] . In addition, the phosphorylation of either phorylation sites demonstrated thus far to be of regulatory of these two sites appears to promote the phosphorylation significance; it is therefore likely that the mechanism of of the other [10, 11] . Considerable evidence indicates p70␤ activation will parallel that of p70␣ [3] [4] [5] . These that PDK1 is responsible for the insulin/mitogen-stimukinases contain a centrally located kinase catalytic domain lated phosphorylation of the p70 activation loop (e.g., of the AGC subclass, immediately carboxyterminal to p70Thr252). PDK1 phosphorylation catalyzes the direct which is a segment of approximately 65 amino acids that preferential phosphorylation of this site in vitro. Cotransis highly conserved (approximately 40% identity) among fection of p70 with PDK1 results in p70 activation, conmost AGC kinases, including the PKBs, PKCs, Rsk comitant with increased phosphorylation at Thr252. Re-(N-terminal catalytic domain), and SGKs. The p70 seciprocally, kinase-inactive ATP site mutants of PDK1 quences flanking these two domains, i.e., an N-terminal block serum/insulin-stimulated phosphorylation of the segment of 64-88 amino acids and a 104 amino acid carp70 activation loop [15, 16] . Embryonic stem (ES) cells boxyterminal tail, are entirely unique to the p70 kinases; lacking PDK1 show no IGF-1-stimulated phosphorylation each flank contains important regulatory motifs. The iniof the p70 activation loop [17] . tial step in p70 activation is the phosphorylation of a cluster of 4-5 (Ser/Thr)Pro motifs situated within a psuedoBy contrast, the kinase responsible for the insulin/mitogen-stimulated phosphorylation of the p70 hydrophobic substrate autoinhibitory domain in the carboxyterminal noncatalytic tail [6] [7] [8] ; phosphorylation does not activate site (e.g., p70Thr412) is not known. This site can be phosphorylated in vitro by the mTOR kinase [18, 19] , and p70 catalytic function [9] but serves to dislodge the tail from the catalytic domain and thereby provides access to its phosphorylation is concomitant with p70 activation. Subsequent phosphorylation of p70 by PDK1 gives a the activating kinases [10, 11] . Two sites of activating phosphorylation have been established with certainty; one strongly synergistic increase in p70 activity [19] . Nevertheless, a Rapamycin-resistant p70 mutant (⌬2-46/ is located in the p70 catalytic subdomain VIII on the ⌬CT104) exhibits unimpaired insulin-stimulated phosantibody, previously employed for the characterization of p70␣ Thr412PO 4 Ϫ during transient expression in vivo phorylation at the Thr412 site in vivo in the presence of [10] . The baculoviral recombinant p70⌬CT104 polypepRapamycin at concentrations sufficient to fully inhibit tide substrate showed no ability to catalyze Thr412 phosthe activity of the endogenous mTOR kinase [20] . The phorylation during incubation in vitro with Mg ϩϩ ATP p70Thr412 site also undergoes phosphorylation in vivo on (Figures 1 and 3b) . coexpression of p70 with PDK1 [21] , and ES cells lacking PDK1 exhibit no IGF-1-stimulated phosphorylation at
Extracts from HEK293 cells, added directly or after p70Thr412, although phosphorylation of the homologous adsorption/elution on Fast Q-Sepharose, gave no detectsite in PKB␣ (Ser473) is unimpaired [17] . PDK1 can phosable Thr412 phosphorylation; however, the Fast Q flowphorylate p70Thr412 directly in vitro, although at a rate through fraction catalyzed significant Thr412 phosphory-Ͻ5% the rate at which it phosphorylates p70Thr252. A lation. This activity was further purified by sequential fragment of the PKC-related kinase, PRK2, that encomadsorption/elution from S-Sepharose, Blue Agarose, and passes the binding site for PDK1 inhibits PDK1-stimuHeparin-Sepharose. The Thr412 kinase activity eluted lated p70Thr412 phosphorylation in vitro, as well as insuat each of these steps in a single major peak; however, lin/mitogen-stimulated phosphorylation of p70Thr412 in purification of HEK293 extracts beyond the Heparinvivo [21] . These data indicate that PDK1 is critical to Sepharose step was limited by low recovery. Consep70Thr412 phosphorylation in vivo; however, whether quently, postmicrosomal extracts of rat liver were evaluthis is because of the facilitating effect of Thr252 phosated as an enzyme source and were observed to contain phorylation on Thr412 phosphorylation, the direct phosa major Thr412 kinase activity that exhibited identical phorylation of Thr412 by PDK1, the activation of a chromatographic behavior to that seen with HEK293 exThr412 kinase by PDK1, or some other mechanism retracts. Gel filtration of the Heparin-Sepharose eluate mains to be established.
yielded a single major peak of Thr412 kinase activity at approximately 35 kDa. Subsequent fractionation of this We have partially purified the dominant p70Thr412 kipeak on Mono Q anion exchange chromatography genernase present in extracts of HEK293 cells; an enzyme with ally yielded two peaks. In each isolate, the peak that essentially identical chromatographic behavior was more eluted at 15-35 mM NaCl contained three polypeptide extensively purified from rat liver and was identified as bands ( Figure 1) ; each was subjected to tryptic digestion a novel member of the NIMA family of kinases. Furtherand microcapillary RP-HPLC, and peptide sequence inmore, analysis of ESTs revealed a second, closely related formation was determined by electrospray ionization mass gene product. During the course of this work, Kandli et spectrometry. The spectra obtained from the tryptic dial [22] identified these sequences as murine ESTs and gestion of the 35 kDa polypeptide contained four peptides named them NEK6 and NEK7; we have adopted this that matched with the amino acid sequence of a human nomenclature. The molecular structure and expression of cDNA, AB026289; a subsequent report described the mu-NEK6 and NEK7, as well as a preliminary functional rine version of AB026289 as NEK6 [22] . Our mass spectroanalysis of NEK6, are described in this report. The data scopic analysis identified an additional five peptides that indicate that NEK6 and NEK7, which are widely exmatched with amino acid sequences in murine expressedpressed, most highly in liver, are capable of phosphorylatsequence tag (est) AA102912, subsequently named NEK7. ing and activating the p70S6K in vitro and in vivo in a A full description of our database search and cDNA clonmanner that synergizes strongly with PDK1. The NEKs ing of NEK6/7 cDNAs is provided in the Materials and are thus candidate p70S6K-activating kinases.
methods and with this article online in the Supplementary material. Thus, the 35 kDa p70S6KThr412 kinase we
Results
purified from rat liver is probably a mixture of NEK6 and The p70S6K is phosphorylated at many sites in vivo, and NEK7. Alternatively, this isolate may be entirely NEK7 it can be phosphorylated in vitro at these and other sites in light of the fact that 3 of the 4 peptides attributed to by numerous protein kinases. We sought to detect the NEK6 are identical in mass and/or sequence in NEK7, subset of kinases capable of phosphorylating p70Thr412 whereas 3 of the 5 peptides attributed to NEK7 are enso as to ascertain their identity and determine whether tirely unique to NEK7. The gene encoding human NEK6 they participate in the physiologic regulation of p70S6K is situated on chromosome 9, and that encoding NEK7 activity. To this end, we employed as a substrate a bacuis on human chromosome 1; these two facts indicate that loviral recombinant p70⌬CT104 mutant, dephosphory-NEK6 and NEK7 are the products of separate genes. A lated at Thr412 in situ by the treatment of sf9 cells with C. elegans protein kinase (Z50873) is about 75% identical Rapamycin (0.1 M, 30 min) prior to extraction. The to both NEK6 and NEK7 ( Figure 2 ). inactive p70⌬CT104 polypeptide was purified to Ͼ90% purity by sequential anion and cation exchange chroma-NEK mRNA expression tography. The phosphorylation of p70Thr412 was decDNA probes reactive selectively with NEK6 or NEK7 were employed for probing a commercial blot containing tected by immunoblot with an anti-Thr412PO 4 Ϫ peptide
Figure 1
Mono Q fractionation of a p70S6KThr412 kinase activity from rat liver. and NEK7 are most highly expressed in liver. Significant signals for NEK6 are evident in brain and kidney; lowimmunoblotting, NEK6-catalyzed phosphorylation of p70S6K⌬CT104 (wild-type and K123M) occurs in part level expression is evident in all tissues on prolonged exposure (not shown). NEK7 mRNA is abundant in heart on Thr412, and this component is abolished by mutation of p70Thr412 to Ala (Figure 3b,c) . Nevertheless, and kidney and is evident at lower levels in all other tissues examined.
this mutation diminishes overall NEK6-catalyzed p70S6K⌬CT104 phosphorylation by only 20%-30% (Figure 3c) . Thus, NEK6 corresponds to the p70S6KThr412
Recombinant NEK6 phosphorylates p70S6K⌬CT104 kinase purified from liver; however, NEK6 also catalyzes at Thr412 substantial phosphorylation of p70S6K at sites other than The NEK6 and NEK7 cDNAs were transiently expressed Thr412 that are yet to be identified. in HEK293 cells, either as a fusion downstream of GST or with an N-terminal FLAG epitope, and examined for their ability to phosphorylate the p70S6K. In vitro, GSTActivation of p70S6K⌬CT104 by NEK6 in vitro and in intact cells: interaction with PDK1 p70S6K⌬CT104 purified from Rapamycin-treated HEK293 cells exhibits a slight autophosphorylation, which
We next examined the effect of NEK6 on p70S6K activity in the presence and absence of PDK1. Phosphorylation is abolished by mutation of the p70S6K ATP binding site (K123M). NEK6 catalyzes a time-and concentrationof mammalian recombinant GST-p70SK6⌬CT104 by NEK6 resulted in a time-dependent increase in p70S6K dependent phosphorylation of GST-p70S6K⌬CT104 (wild-type and K123M), whereas GST is not phosphoryactivity; this increase reached approximately 3-fold at an overall incorporation of 0. Activation of p70S6K⌬CT104 by NEK6 in intact cells. The reporter bars, lanes 2 and 4) was added to GST-p70S6K⌬CT104 that had plasmid pEBG p70S6K⌬CT104 (2 g) was coexpressed in CHO-IR been previously incubated alone (lanes 1 and 2) or with NEK6 (lanes cells with pCMV5 FLAG vector alone (lanes 1 and 2), pCMV5 Myc-3 and 4). In parallel, the vehicle (hatched bar, lanes 5 and 7) or NEK6 PDK1 alone (0.3 g, lane 7), or pCMV5 FLAG-NEK6 (0.1 g, lanes (hatched bars, lanes 6 and 8) was added to GST-p70S6K⌬CT104 that 3 and 5 or 0.3 g, lanes 4 and 6), alone (lanes 3 and 4) or with in Stage 1 had received the vehicle (lanes 7 and 8) or PDK1 (lanes (lanes 5 and 6) pCMV5 Myc-PDK1 (0.3 g). After serum starvation 5 and 6). The reaction was continued for a further 30 min and was for 16 hr, cells were lysed and the activity of GST-p70S6K⌬CT104 terminated by the addition of SDS electrophoresis buffer. The in GSH-Sepharose isolates was measured; the cell extracts were incorporation of 32 P during the first stage (open bars) and a second immunoblotted for Myc and FLAG, and the GSH isolates were stage (hatched bars) is shown in the upper graph, a Coomassie blue immunoblotted for GST and Thr412PO 4 Ϫ , as indicated. Similar results stain of the incubation mixtures after SDS-PAGE is shown in the were obtained in three experiments. middle panel, and an ␣Thr412PO 4 Ϫ immunoblot of the transfer is ylation of p70S6K ⌬CT104 by NEK6 alone substantially p70S6K⌬CT104 (Thr252Ala) (Figure 5a ). Similarly, coexpression of increasing amounts of Myc-PDK1 with FLAGactivated p70S6K; moreover, NEK6 phosphorylation pro-NEK6 in HEK293 cells does not alter the ability of moted PDK1-catalyzed p70S6 phosphorylation, and con-FLAG-NEK6 to catalyze MBP phosphorylation in vitro comitant phosphorylation of p70 by NEK6 and PDK1 (Figure 5c ). Thus, PDK1 does not regulate NEK6 activity, provides a synergistic activation of the p70S6K. NEK6 either directly in vitro or by coexpression in vivo. Reciprocan also phosphorylate GST-PKB in vitro in a Ptd Ins cally, the incubation in vitro of active GST NEK6 with 3,4,5P 3 -independent manner, at a rate approximately 20% baculoviral recombinant PDK1 results in negligible PDK1 that of GST-p70S6K⌬CT104 (Supplementary material).
phosphorylation, although GST-p70S6K⌬CT104 is phosphorylated vigorously by GST NEK6 in a parallel incubaThe ability of NEK6 to activate p70S6K⌬CT104 durtion ( Figure 5b) ; moreover, PDK1 activity toward GST PKB [in the presence of Ptd Ins (3,4,5)P 3 ] is unaltered ing transient expression was examined next. A GSTby NEK6. Similarly, the coexpression of increasing p70S6K⌬CT104 fusion protein, expressed in CHO cells amounts of FLAG-NEK6 with Myc-PDK1 in HEK293 that stably overexpress a recombinant human insulin recells does not alter PDK1 activity toward GST PKB meaceptor (IR), is activated about 3-fold by insulin. This sured in vitro. Thus, there is no crossregulation evident increase in S6K activity is concomitant with increased between PDK1 and NEK6, and this finding indicates that phosphorylation at p70S6KThr412 (Figure 4c ; lanes 1 and their synergistic activation of p70S6K is mediated at the 2). Coexpression of p70S6K⌬CT104 with NEK6 results level of p70S6K itself. in a dose-dependent increase in p70S6K activity. This increase is approximately 2-fold at 0.3 g NEK6 DNA with a role for NEK6 in the physiologic regulation of also activates GST-p70S6K⌬CT104, with 0.3 g PDK1 p70S6K.
To test further this possibility, we examined DNA providing a 3-fold activation similar to that elicited whether a kinase-deficient NEK6 could interfere with the by insulin (Figure 4c; lane 7) . Although PDK1 is a rather ability of insulin to activate the p70S6K. NEK6 (K74M, weak Thr412 kinase in vitro (Figure 4a ; lanes 2 and K75M) was expressed in CHO-IR cells with GST-5 versus lanes 8 and 3), the coexpression of p70S6K p70S6K⌬CT104. Increasing amounts of inactive NEK6 with PDK1 in vivo results in robust phosphorylation at progressively repressed expression of the p70S6K; howThr412PO 4 Ϫ (Figure 4c ; lane 7 versus lane 2). The conever, at levels of kinase-inactive NEK6 that did not affect comitant expression of NEK6 and PDK1 increases the expression of p70S6K reporter polypeptide, we obp70S6K activity in a strongly cooperative fashion, more served an approximately 50% decrease in both the basal than 10-fold greater than the sum of the effects of NEK6 and insulin-stimulated activity of p70S6K⌬CT104. This and PDK1 expressed individually with p70S6⌬CT104 decrease was concomitant with a decrease in phosphoryla- (Figure 4c ; compare lanes 5 and 6 with lanes 4 and 7). tion at Thr412 (Figure 6 ). Thus, a kinase-inactive NEK6 This vigorous activation is accompanied by a clear-cut can interfere with the ability of insulin to phosphorylate synergism in the phosphorylation at Thr412. Thus, NEK6
and activate the p70S6K. alone activates p70S6K in vivo as well as in vitro and acts synergistically with PDK1 both in the activation of NEK6 activity requires serine/threonine phosphorylation and is sensitive to inhibitors of PI 3-kinase p70S6K and in the phosphorylation at p70S6KThr412.
Aliquots of recombinant FLAG-NEK6 that was immunoprecipitated from transiently transfected HEK293 cells
PDK1 and NEK6 do not alter each other's activity
were treated with the serine/threonine protein phosphain vitro or in vivo tase PP2A in the presence or absence of Calyculin A. The The clear-cut synergistic effect of NEK6 and PDK1 on reaction was terminated by the addition of Calyculin A p70S6K activity, especially as observed during coexpresto the previously untreated samples, and NEK6-catalyzed sion in vivo, led us to inquire as to whether NEK6 acti-GST-p70S6K⌬CT104 phosphorylation was measured vates PDK1 or vice versa; this does not appear to be the (Figure 7a ). PP2A abolished the ability of NEK6 to phoscase. Under conditions in vitro where PDK1 catalyzes phorylate GST-p70S6K⌬CT104 and caused the FLAGsignificant (Ptd Ins (3,4,5)P 3 -dependent) phosphorylation NEK6 polypeptide, which characteristically appears on of a recombinant GST-PKB fusion protein, PDK1 cataimmunoblots as a doublet, to collapse to a single species, lyzes negligible 32 P incorporation into NEK6 [in the abcorresponding to the faster migrating band (Figure 7a ). sence of Ptd Ins (3,4,5)P 3 ] and does not alter NEK6 ac-
The total amount of FLAG-NEK6 polypeptide is unaltered by PP2A, and the activity and electrophoretic mobiltivity, measured as the phosphorylation of GST- 5) transiently expressed alone or with increasing amounts of FLAGwere incubated as in (a) in the absence (lanes 2 and 4) or presence NEK6. The kinase activity of Myc-PDK1 toward GST PKB, in the (lanes 3 and 5) of FLAG-NEK6.
P incorporation into PDK1
presence of Ptd Ins 3,4,5P 3 , was assayed in vitro.
Research Paper NEK6 and 7 regulate the p70 S6 kinase Belham, Comb, and Avruch 1163 ment of cells with okadaic acid prior to extraction ( Figure  7b ). Concomitantly, okadaic acid caused an increase in the fraction of NEK6 polypeptide migrating at the slower electrophoretic mobility. We interpret these results as an indication that NEK6 is activated by Ser/Thr phosphorylation; moreover, during transient expression the recombinant NEK6 undergoes partial activation that can be modestly augmented by phosphatase inhibitors and that requires NEK6 catalytic activity. These findings presumably reflect a need for autophosphorylation in vivo.
The phosphorylation of p70S6KThr412 in vivo in response to insulin occurs in a PI 3-kinase-dependent manner [10, 11] . We therefore investigated whether NEK6 activity is modified by insulin or the PI 3-kinase inhibitors, Wortmannin and LY294002. CHO-IR cells transiently expressing NEK6 were deprived of serum overnight; the carrier, Wortmannin (100 nM), or LY294002 (50 M) was added 30 min prior to the addition of buffer or insulin (100 nM), and the cells were harvested 15 min later. Insulin caused a modest increase (1.3-to 1.6-fold) in the activity of recombinant NEK6, which increase was comparable to that seen with okadaic acid (Figure 7c, lanes 5,8) . quots of the same extracts; Figure 7 , lane 2 versus 1) and Thr412 phosphorylation was strongly suppressed by both Wortmannin and LY294002. In contrast to the modest ity of FLAG-NEK6 is not altered if PP2A treatment ocinhibitory effects of Wortmannin and LY294002 pretreatcurs in the presence of Calyculin A. Thus, NEK6 activity ment on recombinant NEK6, Rapamycin did not alter requires NEK6 serine/threonine phosphorylation. It the mobility of recombinant NEK6 on SDS-PAGE or the should be noted that the autophosphorylation of recombi-NEK6 kinase activity assayed after extraction. nant NEK6 in vitro is confined to the upper band of the doublet, and this observation suggests that only this Discussion upper, phosphorylated NEK6 polypeptide possesses kiThis report demonstrates that, in rat liver, the major pronase activity. Moreover, the slowed mobility of wild-type tein kinase activity capable of phosphorylating in vitro NEK6 on SDS-PAGE after expression in vivo appears to Thr412 on the p70S6K comprises a mixture of two closely require NEK6 catalytic activity in light of the fact that related 35 kDa protein kinases in the NIMA family; these NEK6 (K74M, K75M) migrates as a single band whose protein kinases are designated NEK6 and NEK7. Consismobility corresponds to the faster, inactive band observed tent with this conclusion, recombinant NEK6, isolated with wild-type NEK6.
Insulin treatment also caused an increase in the proportion
after transient expression in mammalian cells, phosphorylates the p70S6K in vitro on Thr412. This phosphorylation is accompanied by activation of the p70S6K catalytic funcThe effect of okadaic acid on the activity of recombinant tion. In addition, NEK6 collaborates with PDK1 to pro-NEK6 expressed in HEK293 cells was examined. The duce a synergistic increase in the catalytic activity of activity of FLAG-NEK6, expressed at several levels, was enhanced modestly (between 10%-60%) by the pretreatp70S6K, in vitro and especially in vivo. The mechanisms by which NEK6 and PDK1 cooperate to generate a synercoexpression in vivo is much more robust than that observed for purified PDK1 and NEK6 in vitro suggests gistic activation of p70S6K are not entirely known, but they do not appear to involve any crossactivation of NEK6 that additional factors necessary for the full activation of p70S6K remain to be identified. by PDK1 or vice versa. Based on in vitro experiments, it appears that prior phosphorylation of p70S6K by NEK6
The mammalian family of NIMA-related kinases or NEKs increases both the extent of phosphorylation achieved by currently numbers seven. NIMA, the founding member, a subsequent incubation with PDK1 as well as the size is an Aspergillus nidulans gene product required, in collaboof the increase in p70S6K catalytic activity engendered ration with cdk1, for the initiation and progression of by any level of PDK1-catalyzed p70S6K phosphorylation.
mitosis [23] . The functions of the mammalian NIMAThese responses are consistent with the previous demonrelated kinases are in general poorly understood. The strations that the substitution of an acidic residue for similarity between NIMA and the mammalian NIMA hoThr412 enhances the binding of PDK1 to p70S6K and mologs is largely confined to their (usually) amino-termithat the simultaneous modification of Thr252, the primary site of PDK1 phosphorylation, and Thr412 generates a nally located catalytic domains, which share 40%-50% amino acid sequence identity. NEKs 1-3 contain comstrong, positively cooperative activation of p70 catalytic activity [15] . Nevertheless, NEK6 clearly phosphorylates pletely distinct, nonhomologous carboxy-terminal noncatalytic tails, implying distinct functions and/or regulation. sites on p70S6K other than Thr412; the identification of those sites and their contribution to the regulation of For example, NEK2 is centrosome-associated and, like NIMA, shows peak expression at the G2M boundary [24]. p70S6K is yet to be determined. Moreover, the fact that the activation of p70S6K elicited by NEK6 and PDK1
NEK2 is implicated in centrosome separation through the phosphorylation of the centrosome-associated polypepThr412 phosphorylation in vitro, it greatly diminishes insulin-stimulated p70S6KThr412 phosphorylation in tide NAP2 [25] . In contrast, NEK3 is a cytoplasmic enzyme that is somewhat more abundant in G0 and shows vivo [10] . little variation in activity across the cell cycle [26] .
As regards NEK6, its ability to phosphorylate and activate p70S6K both in vitro and in vivo and to act synergistically NEK6 is the third protein kinase reported to phosphorylate p70S6KThr412, the others being mTOR [18, 19] and with PDK1 is supportive of a physiologic role. In addition, overexpression of a mutant, inactive NEK6 interferes sig-PDK1 [21] itself. The most significant question is whether any of these function physiologically as p70S6KThr412 nificantly with the ability of insulin to activate p70S6K and promote Thr412 phosphorylation; this finding sugkinases, and under what circumstances. The mTOR kinase phosphorylates p70S6K at Thr412 and several other gests that NEK6 can interact with and sequester one or more of the elements necessary for the insulin activation sites in vitro, and it collaborates in vitro with PDK1 in a manner quite similar to that described herein for NEK6; of p70S6K. In light of the fact that insulin-stimulated p70Thr412 phosphorylation is inhibited by Wortmannin phosphorylation of p70S6K by mTOR increases p70S6K catalytic activity per se and substantially amplifies the and LY294002, we anticipated that the responsible protein kinase would also be activated by insulin and inhibactivation of p70S6K induced by a subsequent phosphorylation by PDK1 [19] . The phosphorylation of ited by Wortmannin and LY294002. It is evident that recombinant NEK6 spontaneously acquires significant cap70S6KThr412 is strongly inhibited in vivo by the highly specific mTOR inhibitor, Rapamycin [20] . Moreover, the talytic activity during transient expression in mammalian cells; this activity can be abolished by treatment with activity of mTOR (at least as assayed in vitro with eIF-4E BP as a substrate) is reported to be modestly increased PP2A in vitro. Coexpression with PDK1 does not increase NEK6 activity further, although PDK1 strongly activates by insulin [27] . Nevertheless, several observations suggest that although an active mTOR is critical for the insulinp70S6K. Thus, NEK6 is not a PDK1-activated kinase. The activity of recombinant NEK6 is increased modestly stimulated phosphorylation of p70Thr412 in vivo, this requirement is not attributable to mTOR's ability to act (30%-60%) by treatment in vivo with okadaic acid; this increase is associated with slowed mobility on SDSdirectly as an insulin-stimulated p70S6KThr412 kinase.
PAGE, and a comparable mild activation is elicited in Thus, the properties and specificity of the eIF-4E BPresponse to insulin. The physiologic significance of this and p70S6K-directed kinase activities of mTOR are quite modest insulin stimulation is uncertain. The small activadistinct, and we have been unable to detect any insulintion may reflect an artefactually high basal activity associinduced increase in the mTOR kinase activity assayed with ated with transient overexpression. The relatively high a p70S6K substrate [19] . In addition, the p70S6K mutant basal activity of recombinant NEK6 is modestly inhibited ⌬2-46/⌬CT104, which is resistant to inhibition by Rapaby the PI 3-kinase inhibitors, Wortmannin and LY294002, mycin in vivo, nevertheless undergoes substantial insulinat concentrations that engender strong inhibition of stimulated phosphorylation of Thr412 and activation in p70S6K. This finding indicates that the dependence of vivo in the presence of Rapamycin concentrations far in recombinant NEK6 activity on PI 3-kinase activity is only excess of those required for complete dephosphorylation partial. Thus, the regulatory inputs that control NEK6 of Thr412 on wild-type p70S6K and maximal inhibition of activity under physiologic conditions, apart from its demTOR [20] . In view of these observations, we and others pendence on phosphorylation, are as yet unclear. Our have suggested that mTOR regulates p70S6KThr412 efforts to evaluate the regulation of endogenous NEK6/7 phosphorylation in vivo primarily by the inhibition of a have been hampered by an inability to generate antibodies Thr412 phosphatase, probably PP2A [20, 28] .
capable of immunoprecipitating endogenous NEK6/7 polypeptides; cell lines expressing recombinant NEK6 As regards PDK1, although its ability to phosphorylate are currently in preparation. p70Thr412 in vitro is less than 5% that of p70S6KThr252, coexpression of PDK1 with p70S6K engenders consider-
In conclusion, NEK6 is a NIMA-related protein kinase able p70S6KThr412 phosphorylation [15, 21] phorylation, to Ala has no effect on PDK1-catalyzed Assays were carried out at 30 o C for 10 minutes and terminated by the tube) precoupled to Protein G-Sepharose was added to aliquots of supernatant containing equal amounts of total protein and incubated for addition of 10 l 4ϫ Laemmli sample buffer. Samples were resolved by SDS-PAGE, transferred to PVDF membrane, and immunoblotted with 3 hr at 4 o C. Immunoprecipitates were washed three times in lysis buffer, three times in lysis buffer containing 0.5 M LiCl, and three times in kinase anti-phospho-Thr412 specific antibodies as described in [10] . As a positive control for the phospho-Thr412 Western blot, active, recombibuffer (50 mM MOPS, 10 mM MgCl 2 , 2 mM EGTA, 1 mM DTT, 20 mM ␤-glycerophosphate, and 1 M Calyculin A). An assay of immunoprecipinant p70S6K⌬CT104, purified from Sf9 cells coinfected with baculoviral p70S6K⌬CT104 and a constitutively active PI 3-kinase p110 catalytic tated recombinant NEK6 was carried out under conditions identical to those described for the assay of rat liver kinase activity toward subunit [12] , was run in a separate lane. p70S6KThr412 (see above) except that nonradioactive ATP was replaced by 10 M [␥-32 P]ATP (5000-6000 cpm/pmol), and occasionally
Cloning of NEK6 and NEK7 and construction myelin basic protein (0.5 mg/ml) was used in place of p70S6K⌬CT104.
of expression vectors
Phosphate transfer into NEK6 substrate was quantified by liquid scintillaThe entire open reading frame of human NEK6 and mouse NEK7 was tion counting. derived by interrogation of the dbEST database at the National Center for Biological Information (http://www.ncbi.nlm.nih.gov/dbEST/index.html)
For evaluation of the regulation by NEK6 and/or PDK1 of for overlapping est sequences. In addition, a ZAP II F442A mouse p70S6K⌬CT104 in intact cells and the ability of kinase-deficient NEK6 3T3 L1 adipocyte cDNA library was screened by the polymerase chain to interfere with insulin activation of p70S6K⌬CT104 in intact cells, CHO-IR reaction (PCR) and the use of nested forward or reverse primers correcells were cotransfected with the appropriate pCMV5 expression consponding to complementary sequences within regions found to be invaristructs (or empty vectors) together with pEBG2T p70S6K⌬CT104 as able in overlapping ESTs (encoding subdomain II of mouse NEK7 kinase the reporter plasmid; a constant total amount of DNA was used. GSTdomain and subdomain VIb of mouse NEK6) and primers annealing to p70S6K⌬CT104 was affinity purified from cell lysates on GSH-Sephathe T3 and T7 promoters in ZAP II. Confirmation of the sequence of rose, and its activity was measured by a peptide kinase assay, described the entire open reading frame of mouse NEK6 and NEK7 was achieved below. by automated DNA sequence analysis of PCR fragments. Amplification by PCR of the open reading frame of human NEK6 was obtained from
Activation of p70S6K⌬CT104 by NEK6 and/or PDK1 in vitro
a human skeletal-muscle cell library by the use of the forward primer GST-p70S6K⌬CT104 purified from Rapamycin-treated HEK293 cells 5Ј-CCGGAATTCTATGGCAGGACAGCCCGGCCACATGCCCCAT was further dephosphorylated with PP2A in a buffer containing 50 mM GGAGGGAGTTCC-3Ј and the reverse primer 5Ј-GGCGAATTCTCAG Tris (pH 8.0), 0.1 mM EGTA, 1 mM DTT and 1U/ml PP2A. After incuba-GTGCTGGACATCCAGATGTGCAT-3Ј. The product was subcloned tion at 30 o C for 30 min, Calyculin A was added to a final concentration as an EcoRI fragment into the mammalian expression vector pCMV5-of 10 M. The activation of GST-p70S6K⌬CT104 by NEK6 and/or FLAG, screened for correct orientation by digestion with BamHI, and PDK1 in vitro was carried out in three stages. In the first stage, a 5 l verified by DNA sequencing. An identical approach was used for the aliquot of either GST-NEK6 (1.2 g), baculoviral PDK1 (2.2 g), or the generation of a pCMV5-FLAG-NEK7 expression construct, for which vehicle was added to 2 g PP2A-treated GST-p70S6K⌬CT104 or GST. the forward primer 5Ј-CCGGAATTCTATGGATGAACAATCACAAG The phosphorylation reaction (25 l), containing 50 mM MOPS (pH GAATGCAAG-3Ј and the reverse primer 5Ј-CCGGAATTCCTATTAGG 7.4), 10 mM MgCl 2 , 2 mM EGTA, 20 mM ␤-glycerophosphate, and 1 TGCTTGCGGTACATGCATGC-3Ј were used, with both mouse embry-M Calyculin A, was initiated by the addition of unlabeled ATP (100 onic or T-cell cDNA libraries as a template.
M) and incubated for 30 min at 30 o C. After stage 1, reactions were placed on ice. In the second stage of the assay, 15 l of either GST-A kinase-deficient version of NEK6 was constructed by PCR mutation of NEK6 (1.2 g), baculoviral PDK1 (2.2 g), or the vehicle diluted in the both K74 and K75, lysine residues presumably critical for ATP phosphate same kinase buffer constituents (including 100 M unlabeled ATP) was binding, to M. Subcloning both wild-type and K74M/K75M NEK6 variants added to the appropriate tubes, which were incubated for a further into the pEBG2T plasmid enabled the expression of NEK6 variants as 30 min at 30 C. In stage 3, the activity of GST-p70S6K⌬CT104 was GST-fusion proteins in mammalian cells. The construction of pEBG measured by the use of a synthetic peptide as a substrate; two equal p70S6K␣1⌬CT104 variants and Myc-tagged PDK1 has been described aliquots were taken from each tube and mixed with the vehicle or the previously [15] . p70S6K substrate peptide KKRNRTLTV. The p70S6K reaction (40 l containing 100 M KKRNRTLTV peptide and 100 M [␥- in reactions with GST-p70S6K⌬CT104 or GST when the peptide was in an atmosphere containing 5% CO 2 . CHO-IR cells were maintained absent. One unit (U) of p70S6K activity is defined as the incorporation under 0.66 g/ml Geneticin (Gibco BRL) selection in Ham F-12 nutrient of 1 nmol phosphate into KKRNRTLTV peptide per minute. mixture (Gibco BRL) supplemented with 10% FCS.
Phosphorylation of GST-p70S6K⌬CT104 by NEK6
For the examination of NEK6 regulation in CHO-IR cells, 10 cm plates and/or PDK1 at 80% confluency were transfected with pCMV5 FLAG-NEK6 plasmid For quantification of the amount of phosphate incorporated into GST-DNA (0.03-1 g) in 5 ml OPTI-MEM1 media by the use of Lipofectamine p70S6K⌬CT104 by NEK6 and/or PDK1 in each stage of the assay reagent (Gibco BRL) according to the manufacturers instructions. After described above, identical reactions were carried out in parallel except 5 hr, cells were supplemented with 5 ml Ham F-12 (20% FCS) media that [␥-32 P]ATP (2000-3000 cpm/pmol) was used instead of unlabeled containing 0.66 g/ml Geneticin. After 16 hr, the medium was replaced ATP during the first and second stages. These reactions were terminated with Ham F-12 (10% FCS) media. After a further 10 hr, the cells were by the addition of Laemmli sample buffer (1ϫ final concentration). Samserum-deprived overnight (16 hr) before treatment with Wortmannin, ples were resolved by SDS-PAGE and transferred to PVDF membrane. LY294002, and/or insulin. Cells were extracted in ice-cold buffer A After Coomassie blue staining and visualization by autoradiography, the supplemented with Complete protease inhibitor cocktail (1 tablet/50 membranes were immunoblotted with anti-phospho-Thr412 specific mls), 50 nM Calyculin A, 1 mM Na 3 VO 4 , and 0.2% Triton X-100 and centrifuged for 20 minutes at 13,000 ϫ g. Anti-FLAG antibody (2 g/ antibodies. Coomassie-stained bands corresponding to GST- 
